ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Hot Features

Registration Strip Icon for pro Trade like a pro: Leverage real-time discussions and market-moving ideas to outperform.
Sthree Plc

Sthree Plc (STEM)

269.50
-6.00
(-2.18%)
Closed January 13 11:30AM

Real-time discussions and trading ideas: Trade with confidence with our powerful platform.

Key stats and details

Current Price
269.50
Bid
270.50
Ask
272.00
Volume
345,902
271.00 Day's Range 277.50
230.00 52 Week Range 457.50
Market Cap
Previous Close
275.50
Open
275.50
Last Trade Time
Financial Volume
942,167p
VWAP
272.3797
Average Volume (3m)
268,505
Shares Outstanding
135,502,015
Dividend Yield
6.20%
PE Ratio
6.56
Earnings Per Share (EPS)
0.41
Revenue
1.66B
Net Profit
56.05M

About Sthree Plc

Sector
Employment Agencies
Industry
Employment Agencies
Website
Headquarters
London, Gbr
Founded
-
Sthree Plc is listed in the Employment Agencies sector of the London Stock Exchange with ticker STEM. The last closing price for Sthree was 275.50p. Over the last year, Sthree shares have traded in a share price range of 230.00p to 457.50p.

Sthree currently has 135,502,015 shares outstanding. The market capitalization of Sthree is £373.31 million. Sthree has a price to earnings ratio (PE ratio) of 6.56.

STEM Latest News

SThree plc Transaction in Own Shares

SThree plc 10 January 2025     10th January 2025 SThree plc ("SThree" or the "Company") Transaction in Own Shares   The Company announces today that, in accordance with the terms of its share...

SThree plc Transaction in Own Shares

SThree plc 09 January 2025     9th January 2025 SThree plc ("SThree" or the "Company") Transaction in Own Shares   The Company announces today that, in accordance with the terms of its share...

SThree plc Transaction in Own Shares

SThree plc 08 January 2025     8th January 2025 SThree plc ("SThree" or the "Company") Transaction in Own Shares   The Company announces today that, in accordance with the terms of its share...

SThree plc Transaction in Own Shares

SThree plc 07 January 2025     7TH January 2025 SThree plc ("SThree" or the "Company") Transaction in Own Shares   The Company announces today that, in accordance with the terms of its share...

SThree plc Transaction in Own Shares

SThree plc 06 January 2025     6th January 2025 SThree plc ("SThree" or the "Company") Transaction in Own Shares   The Company announces today that, in accordance with the terms of its share...

SThree plc Transaction in Own Shares

SThree plc 03 January 2025     3rd January 2025 SThree plc ("SThree" or the "Company") Transaction in Own Shares   The Company announces today that, in accordance with the terms of its share...

SThree plc Total Voting Rights

SThree plc 02 January 2025   2 January 2025   SThree plc Total Voting Rights     In conformity with the Financial Conduct Authority's Disclosure Guidance and Transparency Rule 5.6.1R, SThree...

SThree plc Transaction in Own Shares

SThree plc 02 January 2025     2nd January 2025 SThree plc ("SThree" or the "Company") Transaction in Own Shares   The Company announces today that, in accordance with the terms of its share...

SThree plc Transaction in Own Shares

SThree plc 31 December 2024     31st December 2024 SThree plc ("SThree" or the "Company") Transaction in Own Shares   The Company announces today that, in accordance with the terms of its...

SThree plc Transaction in Own Shares

SThree plc 30 December 2024     30th December 2024 SThree plc ("SThree" or the "Company") Transaction in Own Shares   The Company announces today that, in accordance with the terms of its...

PeriodChangeChange %OpenHighLowAvg. Daily VolVWAP
1-13.5-4.7703180212283297.5267272082283.09557126DE
4-0.5-0.185185185185270297.5253.5265731275.63642133DE
12-90-25.0347705146359.5379.5230268505316.68682485DE
26-148.5-35.5263157895418442230235030353.74506938DE
52-122-31.1621966794391.5457.5230241377388.44471445DE
156-158.5-37.0327102804428495230273520393.37732068DE
260-30.5-10.1666666667300610195.2292832391.18382151DE

STEM - Frequently Asked Questions (FAQ)

What is the current Sthree share price?
The current share price of Sthree is 269.50p
How many Sthree shares are in issue?
Sthree has 135,502,015 shares in issue
What is the market cap of Sthree?
The market capitalisation of Sthree is GBP 373.31M
What is the 1 year trading range for Sthree share price?
Sthree has traded in the range of 230.00p to 457.50p during the past year
What is the PE ratio of Sthree?
The price to earnings ratio of Sthree is 6.56
What is the cash to sales ratio of Sthree?
The cash to sales ratio of Sthree is 0.22
What is the reporting currency for Sthree?
Sthree reports financial results in GBP
What is the latest annual turnover for Sthree?
The latest annual turnover of Sthree is GBP 1.66B
What is the latest annual profit for Sthree?
The latest annual profit of Sthree is GBP 56.05M
What is the registered address of Sthree?
The registered address for Sthree is LEVEL 16, 8 BISHOPSGATE, LONDON, EC2N 4BQ
What is the Sthree website address?
The website address for Sthree is www.sthree.com
Which industry sector does Sthree operate in?
Sthree operates in the EMPLOYMENT AGENCIES sector

Movers

View all
  • Most Active
  • % Gainers
  • % Losers
SymbolPriceVol.
SCGLSealand Capital Galaxy Limited
4.60p
(43.75%)
10.46M
APHAlliance Pharma Plc
61.10p
(37.77%)
39.55M
NFXNuformix Plc
0.065p
(36.84%)
93.97M
PRMProteome Sciences Plc
4.50p
(31.58%)
1.06M
RCGHRc365 Holding Plc
2.10p
(31.25%)
2.88M
NTQEnteq Technologies Plc
0.775p
(-75.00%)
7.81M
JWNGJaywing Plc
0.625p
(-58.33%)
1.91M
MFAIMindflair Plc
0.825p
(-28.88%)
119.03M
WBIWoodbois Limited
0.135p
(-22.86%)
447.57M
GEXGeorgina Energy Plc
6.625p
(-22.06%)
5.72M
TRPTower Resources Plc
0.0395p
(6.76%)
9.11B
NTVONativo Resources Plc
0.002p
(-9.09%)
1.27B
DGIDg Innovate Plc
0.0185p
(0.00%)
544.86M
WBIWoodbois Limited
0.135p
(-22.86%)
447.57M
MSMNMosman Oil And Gas Limited
0.033p
(-2.94%)
445.45M

Discussion

View Full Feed
sunspotter sunspotter 9 minutes ago
Dr. Jamil should know that once it is established that the primary endpoint has not been reached, it is widely recognised that it is not valid statistically to declare secondary endpoints and other sub-analyses as having reached statistical significance.

It’s a (not very) sophisticat
GALT
nowwhat2 nowwhat2 15 minutes ago
The Overhead Trendline, The 2.50 Level, The Overall Crypto Sector......

Boy.......what ppl steer clear of considering here is a real mindblower.......


https://investorshub.advfn.com/uimage/uploads/2025/1/13/rmobiXRP_!_12_45d_6pm_GLITCH_OHTL_250_SUMMARY.jpg
XRPUSD
PickStocks PickStocks 17 minutes ago
You contradict yourself......" style="caret-color: rgb(33, 37, 41); color: rgba(33, 37, 41, 1); font-family: Nunito, serif; background-color: rgba(255, 255, 255, 1); font-size: 1em"IF YOU owned P's, K's, or uq's ? ... the DTC Knows It' ... and, the DTC Knows EXACTLY How Many P's, K's, or uq's ... YO
COOP
Malolo Malolo 18 minutes ago
Hello, I'm a newbie at AIM. Wondering if someone could recommend or provide a good spreadsheet?
roncderu@gmail.com.
OPennyS OPennyS 21 minutes ago
If the predictions are correct it is going to be an interesting week.
VXX
Hoghead7 Hoghead7 23 minutes ago
PORTHOS still on schedule. Seems like spring/summer commissioning
https://www.linkedin.com/posts/porthos-co2_porthos-porthosco-co2-activity-7282763014376677376-qnb-?utm_source=share&utm_medium=member_android

https://www.linkedin.com/posts/activity-7275803191202447360-EX6x?utm
FCEL
mining hound mining hound 32 minutes ago
Hi all, thanks for happy new year wishes and I wish the same for all here too!
HLLXF
gfp927z gfp927z 41 minutes ago
>>> Abbott Laboratories (NYSE: ABT) is a well-diversified healthcare company, with four distinct units: Medical devices, diagnostics, nutrition, and established pharmaceuticals. This is great because it means if one of these businesses faces tough times, another could compensate and maintain overall
ABT
gfp927z gfp927z 41 minutes ago
>>> Abbott Laboratories (NYSE: ABT) is a well-diversified healthcare company, with four distinct units: Medical devices, diagnostics, nutrition, and established pharmaceuticals. This is great because it means if one of these businesses faces tough times, another could compensate and maintain overall
ABT
georgebailey georgebailey 42 minutes ago
Steady I think the rubber hits the road when we see the MHRA label assignment on L. Based on safety, phase 3 and RWE we just might see a broad scope label which I’ll call a home run.
NWBO
Birdbrain Ideas Birdbrain Ideas 43 minutes ago
If what you suggest is a possibility, I would view the early December "Investor's Day" in hindsight as more of a dog and pony show for potential buyers. At this point, investors have been beaten to the point that most of us would accept if the company was sold for $6 or $7 a share. What would that b
AMRN
devil dog 96 devil dog 96 45 minutes ago
In October of 2023 The best setup in the OTC challenge was posted and ATMH still holds the #1 spot! Not one ticker has been found with a better setup! 🏆️

If anyone wants to take the challenge and prove me wrong here is the link https://investorshub.advfn.com/b
ATMH
3jack 3jack 45 minutes ago
We will persevere!
AVXL
gfp927z gfp927z 46 minutes ago
>>> Intuitive Surgical (NASDAQ: ISRG) is the global leader in robotic surgery. With a compound annual growth rate of about 15%, this market is expected to reach more than $25 billion by 2030, according to Meticulous Research. Intuitive's flagship product is the da Vinci, a system used in a wide vari
ISRG
3jack 3jack 46 minutes ago
We know who you are!
AVXL
gfp927z gfp927z 46 minutes ago
>>> Intuitive Surgical (NASDAQ: ISRG) is the global leader in robotic surgery. With a compound annual growth rate of about 15%, this market is expected to reach more than $25 billion by 2030, according to Meticulous Research. Intuitive's flagship product is the da Vinci, a system used in a wide vari
ISRG
Lazerator Lazerator 48 minutes ago
Not "walking dead", just dead. I just wish they'd declare bankruptcy instead of pretending like it's going to trade again.
Lazerator Lazerator 50 minutes ago
Clearly, Port turned out to be the fool. Actually, he made fools of all you guys who bought into his scam.
imho imho 50 minutes ago
In the comment section of this article,
https://seekingalpha.com/article/4748984-playing-the-odds-of-anavex-alzheimers-drug-approval#scroll_comments

Someone named Stephen Ayers in his Saturday, 12:42PM comment, says

I asked ChatGPT why the following statement, w
AVXL
Ryoko Ryoko 51 minutes ago
It's not going to be audited. They lied again. They do that once a year. Been that way for the last 4 years.
IBGR
axelvento axelvento 54 minutes ago
has announced that it will be paying its dividend of $0.43 on the 7th of March, an increased payment from last year's comparable dividend. This makes the dividend yield 6.5%, which is above the industry average

$PFE
PFE
Steady_T Steady_T 56 minutes ago
You might be correct about the size of the GBM market in the UK. However you are missing the point.

Approval in the UK validates the MOA and the potential of treating other solid cancers. That will have much more impact than the limited size of the UK market.

Approval
NWBO
skitahoe skitahoe 57 minutes ago
While I'd love you to be right, that would represent over a $14 billion market cap, I believe that's high until the EDEN is available for production of the vaccine. I just don't believe that enough vaccine can be produced in Sawston to justify that market cap until they can make more, which require
NWBO
Saving Grace Saving Grace 57 minutes ago
Putz: We are not at 2 years. Who's we? LoL SMH

Keep an eye on the door. Big revelation! It's coming. UK
NB

Your Recent History

Delayed Upgrade Clock